Biomark Diagnostics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Sep '24 Sep 24, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2019 - 2015
Market Capitalization	20	25	15	16	31	13	Upgrade
Market Cap Growth	-21.18%	60.95%	-1.62%	-48.77%	128.35%	304.23%	Upgrade
Enterprise Value	22	26	17	17	31	14	Upgrade
Last Close Price	0.26	0.30	0.21	0.23	0.42	0.18	Upgrade
PE Ratio	-	-17.92	-9.44	-12.33	-28.14	-10.56	Upgrade
PS Ratio	140.09	152.12	100.50	356.91	-	50.91	Upgrade
PB Ratio	-27.90	-40.73	-13.42	-24.67	-386.98	-30.52	Upgrade
P/FCF Ratio	-17.09	-25.16	-16.77	-12.41	-37.91	-29.49	Upgrade
P/OCF Ratio	-17.21	-25.27	-16.87	-13.02	-37.91	-29.54	Upgrade
EV/Sales Ratio	131.14	161.35	110.73	393.16	-	51.81	Upgrade
EV/EBITDA Ratio	-10.54	-15.54	-9.30	-13.52	-30.47	-11.65	Upgrade
EV/EBIT Ratio	-10.47	-15.41	-9.24	-13.45	-30.39	-11.53	Upgrade
EV/FCF Ratio	-20.54	-26.69	-18.48	-13.67	-38.69	-30.01	Upgrade
Debt / Equity Ratio	-2.31	-2.54	-1.44	-3.09	-12.71	-0.02	Upgrade
Debt / FCF Ratio	-1.41	-1.57	-1.80	-1.56	-1.24	-0.02	Upgrade
Asset Turnover	0.19	0.18	0.14	0.04	-	0.78	Upgrade
Quick Ratio	0.14	0.16	0.06	0.31	0.98	0.58	Upgrade
Current Ratio	0.14	0.16	0.08	0.33	1.00	0.58	Upgrade
Return on Assets (ROA)	-135.65%	-117.29%	-104.38%	-66.19%	-80.77%	-220.06%	Upgrade
Return on Capital (ROIC)	-175.56%	-148.56%	-125.52%	-71.12%	-259.30%	-	Upgrade
Earnings Yield	-7.20%	-5.75%	-11.94%	-9.27%	-3.57%	-9.07%	Upgrade
FCF Yield	-5.85%	-3.97%	-5.96%	-8.06%	-2.64%	-3.39%	Upgrade
Buyback Yield / Dilution	-5.11%	-2.97%	-6.22%	-6.31%	-2.82%	-8.16%	Upgrade
Total Shareholder Return	-5.11%	-2.97%	-6.22%	-6.31%	-2.82%	-8.16%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.